| 注册
首页|期刊导航|重庆医学|气管内滴入硝普钠治疗新生儿持续肺动脉高压的临床研究

气管内滴入硝普钠治疗新生儿持续肺动脉高压的临床研究

陈龙 唐仕芳 王南 史源 赵锦宁

重庆医学Issue(11):1315-1316,1319,3.
重庆医学Issue(11):1315-1316,1319,3.DOI:10.3969/j.issn.1671-8348.2014.11.012

气管内滴入硝普钠治疗新生儿持续肺动脉高压的临床研究

Clinical study on intratracheal instillation of sodium nitroprusside for treating persistent pulmonary hypertension of newborn

陈龙 1唐仕芳 1王南 1史源 1赵锦宁1

作者信息

  • 1. 第三军医大学大坪医院野战外科研究所儿科,重庆400042
  • 折叠

摘要

Abstract

Objective To investigate the therapeutic effect and safety of the intratracheal instillation of sodium nitroprusside for treating persistent pulmonary hypertension of newborn (PPHN) .Methods The intratracheal instillation of sodium nitroprusside was used to 19 cases of PPHN under the mechanical ventilation ,and the pulmonary arterial mean pressure(PAMP) ,arterial mean pressure(AMP) ,transcutaneous oxygen saturation(TcSaO2 ) of the right upper and left lower limb at the basic state ,30 ,60 ,120min after intratracheal instillation of sodium nitroprusside were respectively measured and compared .Results Among 19 cases of PPHN ,17 cases had the primary lung disease .Of 17 cases ,14 cases(82 .35% ) had significant decrease of PAMP after intratracheal instillation of sodium nitroprusside ,which was most significant at 30min after therapy and the difference was statistically significant compared with before therapy [(21 .30 ± 4 .200)mm Hg vs .(30 .30 ± 4 .20)mm Hg ,P<0 .05] ,but AMP between before and after therapy had no statistical difference [(56 .00 ± 3 .00)mm Hg vs .(55 .00 ± 6 .00)mm Hg ,P>0 .05] .Conclusion The intratracheal instillation of sodium nitroprusside is the safe ,effective and economic method for treating PPHN .

关键词

硝普钠/持续性胎儿循环综合征/一氧化氮

Key words

nitroprusside/persistent fetal circulation syndrome/nitric oxide

引用本文复制引用

陈龙,唐仕芳,王南,史源,赵锦宁..气管内滴入硝普钠治疗新生儿持续肺动脉高压的临床研究[J].重庆医学,2014,(11):1315-1316,1319,3.

重庆医学

OA北大核心CSTPCD

1671-8348

访问量0
|
下载量0
段落导航相关论文